(Q37871527)

24 August 2017

1 reference

title

Viruses as key regulators of angiogenesis (English)

1 reference

24 August 2017

1 reference

3

Jan Balzarini

1 reference

24 August 2017

4

Sandra Liekens

1 reference

24 August 2017

Kristof Vrancken

1

1 reference

24 August 2017

Peter Vervaeke

series ordinal

2

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Reviews in Medical Virology

24 August 2017

published in

1 reference

24 August 2017

volume

21

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

181-200

1 reference

Angiogenesis in life, disease and medicine

24 August 2017

cites work

1 reference

Hypoxia: a key regulator of angiogenesis in cancer

21 January 2018

1 reference

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

21 January 2018

1 reference

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion

21 January 2018

1 reference

Angiogenesis: regulators and clinical applications

21 January 2018

1 reference

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

21 January 2018

1 reference

CXC chemokines in cancer angiogenesis and metastases

21 January 2018

1 reference

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9.

21 January 2018

1 reference

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

Angiogenin: a review of the pathophysiology and potential clinical applications

21 January 2018

1 reference

The dual role of thymidine phosphorylase in cancer development and chemotherapy

21 January 2018

1 reference

Integrins as "functional hubs" in the regulation of pathological angiogenesis

21 January 2018

1 reference

The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications

21 January 2018

1 reference

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

21 January 2018

1 reference

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways

21 January 2018

1 reference

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

21 January 2018

1 reference

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro

21 January 2018

1 reference

Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus

21 January 2018

1 reference

Kaposi's sarcoma and its associated herpesvirus

21 January 2018

1 reference

Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

21 January 2018

1 reference

Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1

21 January 2018

1 reference

Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion

21 January 2018

1 reference

Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases

21 January 2018

1 reference

Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

21 January 2018

1 reference

Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells

21 January 2018

1 reference

A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia

21 January 2018

1 reference

Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells

21 January 2018

1 reference

Identification of cellular genes targeted by KSHV-encoded microRNAs

21 January 2018

1 reference

MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

21 January 2018

1 reference

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

21 January 2018

1 reference

Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression

21 January 2018

1 reference

The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors

21 January 2018

1 reference

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

21 January 2018

1 reference

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

21 January 2018

1 reference

Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor

21 January 2018

1 reference

The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor

21 January 2018

1 reference

KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway

21 January 2018

1 reference

Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis

21 January 2018

1 reference

Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.

21 January 2018

1 reference

Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins

21 January 2018

1 reference

Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior

21 January 2018

1 reference

Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.

21 January 2018

1 reference

Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt

21 January 2018

1 reference

Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells

21 January 2018

1 reference

Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products

21 January 2018

1 reference

Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein

21 January 2018

1 reference

Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein

21 January 2018

1 reference

The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.

21 January 2018

1 reference

Viral hepatocarcinogenesis

21 January 2018

1 reference

Angiogenesis and hepatocellular carcinoma

21 January 2018

1 reference

Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis

21 January 2018

1 reference

Expression of hepatitis B virus X (HBx) gene is up-regulated by adriamycin at the post-transcriptional level

21 January 2018

1 reference

Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway

21 January 2018

1 reference

Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery

21 January 2018

1 reference

Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein

21 January 2018

1 reference

The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus

21 January 2018

1 reference

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

21 January 2018

1 reference

The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases

21 January 2018

1 reference

Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3.

21 January 2018

1 reference

Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis

21 January 2018

1 reference

The potential of angiogenesis soluble markers in chronic hepatitis C.

21 January 2018

1 reference

Angiogenesis in chronic hepatitis C is associated with inflammatory activity grade and fibrosis stage.

21 January 2018

1 reference

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1 and Stimulates the Synthesis of Vascular Endothelial Growth Factor

21 January 2018

1 reference

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

21 January 2018

1 reference

Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways

21 January 2018

1 reference

Hepatitis B virus/hepatitis C virus upregulate angiopoietin-2 expression through mitogen-activated protein kinase pathway

21 January 2018

1 reference

HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.

21 January 2018

1 reference

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

21 January 2018

1 reference

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins

21 January 2018

1 reference

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

21 January 2018

1 reference

Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism

21 January 2018

1 reference

Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells

21 January 2018

1 reference

Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.

21 January 2018

1 reference

Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma

21 January 2018

1 reference

Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.

21 January 2018

1 reference

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

21 January 2018

1 reference

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies.

21 January 2018

1 reference

The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.

21 January 2018

1 reference

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway

21 January 2018

1 reference

Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.

21 January 2018

1 reference

Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis.

21 January 2018

1 reference

Angiogenic properties of human immunodeficiency virus type 1 Tat protein

21 January 2018

1 reference

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

21 January 2018

1 reference

Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection

21 January 2018

1 reference

Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins

21 January 2018

1 reference

Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing

21 January 2018

1 reference

IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin

21 January 2018

1 reference

The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants

21 January 2018

1 reference

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis.

21 January 2018

1 reference

The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.

21 January 2018

1 reference

The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice

21 January 2018

1 reference

Update on human herpesvirus 6 biology, clinical features, and therapy

21 January 2018

1 reference

Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6.

21 January 2018

1 reference

U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis

21 January 2018

1 reference

HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines.

21 January 2018

1 reference

Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis

21 January 2018

1 reference

Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection.

21 January 2018

1 reference

Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus

21 January 2018

1 reference

Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis

21 January 2018

1 reference

Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis

21 January 2018

1 reference

Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses.

21 January 2018

1 reference

Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene

21 January 2018

1 reference

Adenoviruses increase endothelial cell proliferation, migration, and tube formation: partial reversal by the focal adhesion kinase inhibitor, FRNK.

21 January 2018

1 reference

Vascular endothelium: the battlefield of dengue viruses

21 January 2018

1 reference

STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling.

21 January 2018

1 reference

Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways

21 January 2018

1 reference

The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element

21 January 2018

1 reference

Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells

21 January 2018

1 reference

EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors

21 January 2018

1 reference

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.688

1 reference

24 August 2017

1 reference